✦ LIBER ✦

The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model

✍ Scribed by Feifei Luo; Chao Li; William G. Ondo; Pingyi Xu; Wenjie Xie; Weidong Le

Book ID: 116884952
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 254 KB
Volume: 12
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2010.07.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term use of pramipexole in the mana

Long-term use of pramipexole in the management of restless legs syndrome

✍ Lipford, Melissa C.; Silber, Michael H. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Augmentation: A Specific Problem in the

Augmentation: A Specific Problem in the Long-Term Treatment of Restless Legs Syndrome

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

Ropinirole is effective in the long-term

Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial

✍ Jacques Montplaisir; Jeff Karrasch; Jean Haan; Dieter Volc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 1 views

## Abstract The objective of this study was to investigate the long‐term efficacy of ropinirole in patients with restless legs syndrome (RLS) and to assess the potential for relapse after the discontinuation of active treatment. Patients with primary RLS (n = 202) received single‐blind ropinirole f

A 10-year, longitudinal assessment of do

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome

✍ Nathan Silver; Richard P. Allen; Julia Senerth; Christopher J. Earley 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 304 KB

Open-label study of the long-term effica

Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)

✍ Markku Partinen; Kari Hirvonen; Leni Jama; Anniina Alakuijala; Christer Hublin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

A 52-week open-label study of the long-t

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

✍ Diego Garcia-Borreguero; Ronald Grunstein; Guruswamy Sridhar; Tilman Dreykluft; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 159 KB